Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study

The benefit of colonoscopy and/or polypectomy for colorectal cancer (CRC) prevention in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. We aimed to estimate the incidence rate of CRC in patients with NAFLD who had and had not undergone colonoscopy. We conducted a retrospective territory‐wide cohort study for patients aged over 40 years with NAFLD identified with the International Classification of Diseases, Ninth Revision, Clinical Modification codes between January 1, 2000, and December 31, 2014. Patients were followed until CRC diagnosis, death, or December 31, 2017. We estimated CRC incidence and standardized incidence ratio (SIR) using the general population of Hong Kong as reference. We included 8,351 patients with NAFLD in the final analysis (median age, 56.2 years; interquartile ratio [IQR], 49.2‐65.3 years; 45.4% male; median follow‐up, 7.4 years; IQR, 5.4‐9.6 years). Compared with the general population, patients with NAFLD who had not undergone colonoscopy had a higher incidence of CRC (SIR, 2.20; 95% confidence interval [CI], 1.64‐2.88; P < 0.001). Patients with NAFLD who had undergone colonoscopy had a lower incidence of CRC (SIR, 0.54; 95% CI, 0.37‐0.75; P < 0.001), especially among those aged above 50 years or with diabetes mellitus (DM). Patients with NAFLD with a high fibrosis‐4 (FIB‐4) score (>2.67) had a significantly higher risk of CRC after adjusting for demographic and metabolic factors. Conclusion: Patients with NAFLD who had undergone colonoscopy had a lower incidence of CRC than the general population, especially among those aged ≥50 years or with DM. A high FIB‐4 index was associated with a higher risk of CRC.

[1]  H. Tilg,et al.  Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals , 2020, Gut.

[2]  V. Wong,et al.  Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[3]  L. Wilkens,et al.  Associations Between Reproductive and Hormone-related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  G. Colditz,et al.  Metabolic syndrome, metabolic comorbid conditions, and risk of early-onset colorectal cancer. , 2020 .

[5]  Shuohua Chen,et al.  Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  V. Wong,et al.  High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study , 2020, BMC Gastroenterology.

[7]  A. Iannelli,et al.  Colorectal Cancer Risk Following Bariatric Surgery in a Nationwide Study of French Individuals With Obesity. , 2020, JAMA surgery.

[8]  D. Ransohoff,et al.  Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. , 2020, Gastroenterology.

[9]  Christopher D. Jensen,et al.  Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. , 2020, Gastroenterology.

[10]  N. Bhala,et al.  Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. , 2020, Gastroenterology.

[11]  F. Violi,et al.  Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  I. Tomlinson,et al.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) , 2019, Gut.

[13]  A. Jemal,et al.  Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.

[14]  R. Pfeiffer,et al.  Circulating inflammatory markers and colorectal cancer risk: A prospective case‐cohort study in Japan , 2018, International journal of cancer.

[15]  W. Willett,et al.  Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer , 2018, JNCI cancer spectrum.

[16]  R. Clarke,et al.  Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People , 2018, Hepatology.

[17]  K. Wong,et al.  Recommendations on prevention and screening for colorectal cancer in Hong Kong. , 2018, Hong Kong medical journal = Xianggang yi xue za zhi.

[18]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[19]  V. Wong,et al.  Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment , 2018, Alimentary pharmacology & therapeutics.

[20]  Antonio Felix Conde-Martin,et al.  Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. , 2018, Gastroenterology.

[21]  M. Ezzati,et al.  Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment , 2018, The lancet. Diabetes & endocrinology.

[22]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[23]  R. Hultcrantz,et al.  Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. , 2017, Journal of hepatology.

[24]  A. Mattioli,et al.  Mediterranean diet and colorectal cancer: A systematic review. , 2017, Nutrition.

[25]  Vincent Wai-Sun Wong,et al.  New trends on obesity and NAFLD in Asia. , 2017, Journal of hepatology.

[26]  G. Wong,et al.  Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis , 2017, Alimentary pharmacology & therapeutics.

[27]  C. Cheung,et al.  Validity of major osteoporotic fracture diagnosis codes in the Clinical Data Analysis and Reporting System in Hong Kong , 2017, Pharmacoepidemiology and drug safety.

[28]  V. Wong,et al.  Laboratory parameter‐based machine learning model for excluding non‐alcoholic fatty liver disease (NAFLD) in the general population , 2017, Alimentary pharmacology & therapeutics.

[29]  A. Ido,et al.  Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. , 2017, Gastrointestinal endoscopy.

[30]  David A. Drew,et al.  Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. , 2017, Gastroenterology.

[31]  D. Sinn,et al.  Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia , 2017, Alimentary pharmacology & therapeutics.

[32]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[33]  Yin Cao,et al.  Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.

[34]  S. Suh,et al.  Diabetes and Cancer: Is Diabetes Causally Related to Cancer? , 2011, Diabetes & metabolism journal.

[35]  V. Wong,et al.  High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis , 2011, Gut.

[36]  D. Harlan,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[37]  M. Pollak,et al.  Insulin and insulin-like growth factor signalling in neoplasia , 2008, Nature Reviews Cancer.

[38]  F. Chan,et al.  Obstacles to Colorectal Cancer Screening in Chinese: A Study Based on the Health Belief Model , 2008, The American Journal of Gastroenterology.

[39]  B. Yawn,et al.  Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2007, Annals of Internal Medicine.

[40]  V. Wong,et al.  Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[42]  J. Meyerhardt,et al.  Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. , 2005, JAMA.

[43]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[44]  V. Wong,et al.  Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients. , 2017, Journal of hepatology.

[45]  V. Wong,et al.  Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. , 2017, Journal of hepatology.

[46]  V. Bours,et al.  MicroRNAs and Inflammation in Colorectal Cancer. , 2016, Advances in experimental medicine and biology.

[47]  Jennifer S Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[48]  V. Wong,et al.  Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. , 2015, Journal of hepatology.

[49]  R. Pearson High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis , 2011 .

[50]  John T. Woosley,et al.  Circulating levels of inflammatory cytokines and risk of colorectal adenomas. , 2008, Cancer research.

[51]  Vicky Fung,et al.  The Hong Kong Hospital Authority's Information Architecture , 2004, MedInfo.

[52]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[53]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.